For instance, according to Costa et al., STC1 expression markedly increased within prostate cancer tissues, whereas cellular experiments showed a reduction in prostate cancer cell proliferation and an increased cell death rate with STC1 antibody interference (Costa et al., 2020). The gene discussed is STC1; the disease is prostate cancer.